Sadhana Nitro Chem Ltd

BSE Code : 506642
NSE Symbol : SADHNANIQ
ISIN : INE888C01040
Industry :CHEMICALS

Trade Now

Get Quotes

21.77 1.03(4.97%)

Open Price (₹)

21.75

Prev. Close (₹)

20.74

Volume (No’s)

21,293

Market Cap (₹)

717.13

Low Price (₹)

21.75

High Price (₹)

21.77 Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Book Closure

From Date	To Date	Announcement
13-May-2025	28-Apr-2025	Source: BSE Announcement PDF
02-May-2025	NA	Sadhana Nitro Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2025 inter alia to consider and approve SADHANA NITROCHEM LTD has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2025 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulation 2015 we wish to inform you that a meeting of the Board of Directors of Sadhana Nitro Chem Limited (the Company) is scheduled to be held on Friday May 02 2025 inter alia: 1. To consider the Audited Standalone and Consolidated Financial Results and Statements for the quarter and Financial year ended March 31 2025. 2. To Consider the recommendation of Dividend for the financial year 2024-25. 3. Any other business that may arise out of the discussion during the meeting Outcome of Board Meeting held on May 02, 2025 (As per BSE Announcement Dated on 02/05/2025) Outcome of the Board Meeting held on May 02, 2025 (As Per BSE Announcement Dated on 03.05.2025) Reappointment of M/s. Vinay Mulay & Co., as the Cost Auditor of the Company for Financial Year 2025-26 (As per BSE Announcement Dated on 05/05/2025)
31-Mar-2025	NA	Considered and recommended a dividend @ 10% i.e. Rs. 0.10 per equity share of face value of Re.1/- each for the financial year 2024-25 as on the record date to be fixed by the Board subject to approval of shareholders at the ensuing Annual General Meeting.
17-Feb-2025	NA	Catalyst Trusteeship Ltd
03-Feb-2025	NA	SADHANA NITROCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results along with the Limited Review Report of the quarter and nine months period ended December 31 2024. Any other business that may arise out of the discussion during the meeting. Outcome of Board Meeting held on February 3, 2025, to consider financial results for the quarter and nine months period ending December 31, 2024 and other matters. (As Per BSE Announcement Dated on: 03/02/2025)